Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubules.
第一作者:
Danielle M,Burgenske
第一单位:
Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
作者:
主题词
动物(Animals);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);脑肿瘤(Brain Neoplasms);胶质母细胞瘤(Glioblastoma);人类(Humans);小鼠(Mice);微管(Microtubules)
DOI
10.1093/neuonc/noab162
PMID
34232318
发布时间
2024-11-30
- 浏览0

Neuro-oncology
384-395页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文